Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Beijing’s New Fast-track Review For Innovative Medicines Might Be Open Only To Made-in-China Drugs

This article was originally published in PharmAsia News

Executive Summary

BEIJING - China's fast-track review process for certain classes of new drugs, unveiled earlier this month, marks an advance in the country's budding support for innovative medicines, but also might be open only to domestically made products, according to Chinese and American lawyers
Advertisement

Related Content

China's Pro-science Leaders To Make Biotech Drugs A Central Plank In New Five Year Plan
China's Pro-science Leaders To Make Biotech Drugs A Central Plank In New Five Year Plan
Hutchison Medipharma Initiates Phase I Trials Of Cancer-fighting Candidate Sulfatinib In China
Hutchison Medipharma Initiates Phase I Trials Of Cancer-fighting Candidate Sulfatinib In China
Chinese Innovative Drug Developer Hutchison MediPharma Could See Spin-off Ahead, Says Founder
Chinese Innovative Drug Developer Hutchison MediPharma Could See Spin-off Ahead, Says Founder
China Government Report On Drug Regulation Seeks To Increase Transparency
China Government Report On Drug Regulation Seeks To Increase Transparency
Advertisement
UsernamePublicRestriction

Register

SC069902

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel